Apollo Medical Holdings, Inc. (AMEH)
(Delayed Data from NSDQ)
$19.93 USD
+0.41 (2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.93 USD
+0.41 (2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Apollo Medical Holdings, Inc. (AMEH) Soars 7.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
GoodRx Holdings, Inc. (GDRX) Reports Next Week: What Awaits?
by Zacks Equity Research
GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ELV or AMEH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ELV vs. AMEH: Which Stock Is the Better Value Option?
ELV or AMEH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ELV vs. AMEH: Which Stock Is the Better Value Option?
Establishment Labs Holdings Inc. (ESTA) Soars 7.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Apollo Medical Holdings, Inc. (AMEH) Meets Q2 Earnings Estimates
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of 0% and 2.08%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Revvity (RVTY) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Revvity (RVTY) delivered earnings and revenue surprises of 2.54% and 0.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?
by Zacks Equity Research
Investors need to pay close attention to Apollo Medical (AMEH) stock based on the movements in the options market lately.
Zacks Industry Outlook Highlights Medpace, HealthEquity and Apollo Medical
by Zacks Equity Research
Medpace, HealthEquity and Apollo Medical are part of the Zacks Industry Outlook article.
3 Medical Services Stocks to Buy Amid Improving Industry Trends
by Urmimala Biswas
The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and AMEH are set to gain the most. However, staffing shortages may disrupt the trend.
Wall Street Analysts Believe Apollo Medical Holdings, Inc. (AMEH) Could Rally 59.78%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 59.8% in Apollo Medical Holdings, Inc. (AMEH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Here's Why You Should Hold Elevance (ELV) in Your Portfolio
by Zacks Equity Research
Improving top line, investments in high-growth businesses, membership hikes and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
Apollo Medical Holdings, Inc. (AMEH) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Hims & Hers Health (HIMS) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Hims & Hers Health, Inc. (HIMS) and Apollo Medical Holdings, Inc. (AMEH) have performed compared to their sector so far this year.
New Strong Buy Stocks for May 11th
by Zacks Equity Research
AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.
Apollo Medical Holdings, Inc. (AMEH) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of 20% and 1.70%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Cano Health, Inc. (CANO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Cano Health, Inc. (CANO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ELV vs. AMEH: Which Stock Is the Better Value Option?
by Zacks Equity Research
ELV vs. AMEH: Which Stock Is the Better Value Option?
Apollo Medical Holdings, Inc. (AMEH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Teladoc (TDOC): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Apollo Medical Holdings, Inc. (AMEH) Lags Q4 Earnings Estimates
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of -77.78% and 11.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
AMN Healthcare Services (AMN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AMN Healthcare (AMN) delivered earnings and revenue surprises of 14.29% and 5.82%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Initiate Coverage: 4 Stocks to Buy for Higher Return
by Shrabana Mukherjee
Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Dorian (LPG), Agilysys (AGYS), Kyndryl (KD) and Apollo Medical (AMEH).
Apollo Medical Holdings, Inc. (AMEH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Apollo Medical Holdings, Inc. (AMEH) closed at $28.35, marking a +1.83% move from the previous day.